DEPVEN

This brand name is authorized in South Africa

Active ingredients

The drug DEPVEN contains one active pharmaceutical ingredient (API):

1 Desvenlafaxine UNII ZB22ENF0XR - DESVENLAFAXINE SUCCINATE

Desvenlafaxine is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI), indicated for the treatment of major depressive disorder [MDD]. The clinical efficacy of desvenlafaxine is thought to be related to the potentiation of these neurotransmitters in the central nervous system.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEPVEN XL Extended release tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX23	Desvenlafaxine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX23

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/1.2/0048, 53/1.2/0049